Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces $4 Million In-Kind Donation of Medical Devices to FIENS
Effort Supports Neurosurgical Residencies in Developing Countries
View HTML
Toggle Summary Integra LifeSciences Announces $2.8 Million In-Kind Donation of Medical Devices to CURE International
Effort Supports Life-Changing Pediatric Surgeries in Dominican Republic, Uganda and Zambia
View HTML
Toggle Summary Integra LifeSciences and University of Pennsylvania To Present Results of LICOX Brain Tissue Oxygen Monitoring Clinical Experience At the 2006 American Association of Neurological Surgeons -- AANS -- Annual Meeting in San Francisco
Integra LifeSciences and University of Pennsylvania To Present Results of LICOX Brain Tissue Oxygen Monitoring Clinical Experience At the 2006 American Association of Neurological Surgeons -- AANS -- Annual Meeting in San Francisco PLAINSBORO, N.J., April 25, 2006 (PRIMEZONE) -- Integra
View HTML
Toggle Summary Integra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco
Integra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation
View HTML
Toggle Summary Integra LifeSciences and SeaSpine to Present at the Jefferies 2015 Global Healthcare Conference in June
PLAINSBORO, N.J., May 26, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will make the following presentations at the Jefferies 2015 Global Healthcare Conference in New York City: At 4:00PM ET on Tuesday, June 2, 2015, Mr.
View HTML
Toggle Summary Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents
Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents PLAINSBORO, N.J., Aug. 6, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) and REVA Medical, Inc.
View HTML
Toggle Summary Integra LifeSciences and IsoTis to Combine Creating a Global Leader in Orthobiologics
PLAINSBORO, N.J. and IRVINE, Calif., Aug 7, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) ("Integra") and IsoTis, Inc. (Nasdaq:ISOT) ("IsoTis") announced today a definitive agreement whereby Integra would acquire IsoTis in an all cash
View HTML
Toggle Summary Integra LifeSciences Agrees to Acquire Spinal Specialties from I-Flow Corporation
Integra LifeSciences Agrees to Acquire Spinal Specialties from I-Flow Corporation Plainsboro, NJ / October 28, 2003 / -- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced today that it has agreed to acquire Spinal Specialties, Inc.
View HTML
Toggle Summary Integra LifeSciences Adds PET Imaging to Its Cancer Fighting XKnife System
Integra LifeSciences Adds PET Imaging to Its Cancer Fighting XKnife System PLAINSBORO, N.J., Feb. 9, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, released its latest image registration software, ImageFusion™
View HTML
Toggle Summary Integra LifeSciences Acquires Theken Spine
PLAINSBORO, N.J., Aug 4, 2008 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired Theken Spine, LLC, Theken Disc, LLC and Therics, LLC (together "Theken") for $75 million in cash, subject to certain adjustments, and
View HTML